Dorien Van den Bossche
Overview
Explore the profile of Dorien Van den Bossche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ledesma V, Vanbaelen T, Gestels Z, Panis N, Abdellati S, de Block T, et al.
FEMS Microbiol Lett
. 2024 Dec;
371.
PMID: 39657094
Background: The ResistAZM randomized controlled trial found that the receipt of ceftriaxone/azithromycin, compared to ceftriaxone was not associated with an increase in the proportion of oral commensal Neisseria spp. and...
2.
van Griensven J, van Henten S, Kibret A, Kassa M, Beyene H, Abdellati S, et al.
EBioMedicine
. 2024 Nov;
110:105474.
PMID: 39612653
Background: Targeted preventive strategies in persons living with HIV (PLWH) require markers to predict visceral leishmaniasis (VL). We conducted a longitudinal study in a HIV-cohort in VL-endemic North-West Ethiopia to...
3.
Panis N, Gestels Z, Van den Bossche D, De Baetselier I, Abdellati S, Vanbaelen T, et al.
Antibiotics (Basel)
. 2024 Nov;
13(11).
PMID: 39596790
: The use of antimicrobials to treat food animals leaves antimicrobial residues in foodstuffs. The World Health Organization (WHO) defines the acceptable daily intakes (ADIs) of these residues as the...
4.
De Baetselier I, de Block T, Manoharan-Basil S, Lecompte A, Kenyon C, Van den Bossche D
Sex Transm Infect
. 2024 Oct;
PMID: 39443110
No abstract available.
5.
Abdellati S, Gestels Z, Baranchyk Y, de Block T, Van den Bossche D, De Baetselier I, et al.
Int J STD AIDS
. 2024 Sep;
35(13):1042-1049.
PMID: 39226039
Background: The emergence of ceftriaxone-resistant poses a significant threat to existing treatment regimens. Our study aimed to assess the efficacy of antimicrobials that could be combined with ceftriaxone to reduce...
6.
de Block T, De Baetselier I, Van den Bossche D, Abdellati S, Gestels Z, Laumen J, et al.
J Med Microbiol
. 2024 Aug;
73(8).
PMID: 39212029
Commensal spp. are highly prevalent in the oropharynx as part of the healthy microbiome. can colonise the oropharynx too from where it can cause invasive meningococcal disease. To identify ,...
7.
Abdellati S, Gestels Z, Laumen J, Van Dijck C, De Baetselier I, de Block T, et al.
FEMS Microbiol Lett
. 2024 Aug;
371.
PMID: 39210455
Background: commensal Neisseria species are part of the oropharyngeal microbiome and play an important role in nitrate reduction and protecting against colonization by pathogenic bacteria. They do, however, also serve...
8.
Balduck M, Strikker A, Gestels Z, Abdellati S, Van den Bossche D, De Baetselier I, et al.
Pathogens
. 2024 Jul;
13(7).
PMID: 39057765
Background: Tolerance enables bacteria to survive intermittent antibiotic exposure without an increase in antimicrobial susceptibility. In this study, we investigated the presence of tolerance to three antimicrobials, ceftriaxone, azithromycin and...
9.
Baranchyk Y, Gestels Z, Van den Bossche D, Abdellati S, Xavier B, Manoharan-Basil S, et al.
PeerJ
. 2024 Jun;
12:e17463.
PMID: 38827315
Background: The use of antimicrobials to treat food animals may result in antimicrobial residues in foodstuffs of animal origin. The European Medicines Association (EMA) and World Health Organization (WHO) define...
10.
Gestels Z, Baranchyk Y, Van den Bossche D, Laumen J, Abdellati S, Xavier B, et al.
Microbiol Spectr
. 2024 Apr;
12(6):e0359523.
PMID: 38687060
We hypothesized that the residual concentrations of fluoroquinolones allowed in food (acceptable daily intake-ADIs) could select for ciprofloxacin resistance in our resident microbiota. We developed models of chronic and infection...